Remove Clinical Supply Remove Development Remove Genome Remove Reagent
article thumbnail

Overcoming inefficiencies to improve access to cell and gene therapy 

Drug Discovery World

While there is no silver bullet for increasing the availability of CGTs, improving manufacturing processes that enable their development at scale can help reduce the cost of these treatments and get them to those who need them most. But now, the increased efficiency is likely making drug development cheaper.